BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

471 related articles for article (PubMed ID: 19284085)

  • 21. Altered serum concentrations of TGF-beta 1 and Lp(a) lipoprotein and their correlation in patients with first acute myocardial infarction.
    Djurovic S; Thelle DS; Ringstad J; Christensen B; Berg K
    Nutr Metab Cardiovasc Dis; 1999 Oct; 9(5):250-4. PubMed ID: 10656172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of elevated serum lipoprotein (a) concentrations on the risk of coronary heart disease in patients with type 2 diabetes mellitus.
    Murase T; Okubo M; Amemiya-Kudo M; Ebara T; Mori Y
    Metabolism; 2008 Jun; 57(6):791-5. PubMed ID: 18502261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Changes of plasma testosterone level in male patients with coronary heart disease].
    Li X; Zhao S; Li Y; Wang Z; Luo L; Zhou H
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(1):53-6. PubMed ID: 10681796
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity.
    Pietrzak A; Kadzielewski J; Janowski K; Roliński J; Krasowska D; Chodorowska G; Paszkowski T; Kapeć E; Jastrzebska I; Tabarkiewicz J; Lotti T
    Int J Dermatol; 2009 Apr; 48(4):379-87. PubMed ID: 19335423
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conventional lipid profile and lipoprotein(a) concentrations in treated patients with rheumatoid arthritis.
    García-Gómez C; Nolla JM; Valverde J; Gómez-Gerique JA; Castro MJ; Pintó X
    J Rheumatol; 2009 Jul; 36(7):1365-70. PubMed ID: 19369465
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Importance of lipoprotein(a) in patients with ischemic heart disease].
    Nakamura Y; Yokoi Y; Hamaguchi H; Toyonaga T; Kondo T; Takami S; Kubo M; Matsuzawa Y
    J Cardiol; 1992; 22(2-3):319-23. PubMed ID: 1339790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.
    Berneis K; Rizzo M; Hersberger M; Rini GB; Di Fede G; Pepe I; Spinas GA; Carmina E
    Int J Clin Pract; 2009 Jan; 63(1):56-62. PubMed ID: 19125993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A study on the relationship between Lp(a) and arteriosclerotic cerebral infarction].
    Tan Y; Yao C; Shen J
    Zhonghua Liu Xing Bing Xue Za Zhi; 1998 Feb; 19(1):36-8. PubMed ID: 10322706
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Lipoprotein(a) and plasma lipids in 429 elderly and very old subjects: significance as risk factor, effect of nutrition and life style].
    Heinimann K; Stähelin HB; Perrig-Chiello P; Perrig WO; Ehrsam R; Meier B; Krings F
    Schweiz Med Wochenschr; 1996 Aug; 126(35):1487. PubMed ID: 8927952
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiovascular risk factors in non-diabetic hemodialysis patients: a comparative study.
    Tzanatos HA; Tseke PP; Pipili C; Retsa K; Skoutelis G; Grapsa E
    Ren Fail; 2009; 31(2):91-7. PubMed ID: 19212904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1994 Dec; (77):51-8. PubMed ID: 19496273
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipoprotein(a) as a marker for coronary heart disease.
    Duriez P; Dallongeville J; Fruchart JC
    Br J Clin Pract Suppl; 1996 Jan; 77A():54-61. PubMed ID: 8729591
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased levels of lipoprotein (a) are related to family risk factors of cardiovascular disease in children and adolescents from Maracaibo, Venezuela.
    Souki-Rincón A; Urdaneta J; Mengual E; Torres D; Cano-Peñaloza R; García-Camacho D; Bermúdez-Pírela V; Sorell L; Cano-Ponce C; Almarza J; Israili Z; Hernández-Hernandez R; Velasco M
    Am J Ther; 2008; 15(4):403-8. PubMed ID: 18645346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Low plasma HDL-c, a vascular risk factor in high risk patients independent of LDL-c.
    Hajer GR; van der Graaf Y; Bots ML; Algra A; Visseren FL;
    Eur J Clin Invest; 2009 Aug; 39(8):680-8. PubMed ID: 19453647
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Clinical evaluation of risk factors for coronary heart disease].
    Jin YP; Qin GM; Zhang SZ; Li CJ; Xu G
    Zhonghua Yu Fang Yi Xue Za Zhi; 2003 Mar; 37(2):98-101. PubMed ID: 12839659
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Association between lipoprotein(a) and coronary disease].
    Bovet P; Burnand B; Kappenberger L; Riesen W; Darioli R
    Schweiz Med Wochenschr; 1993 Nov; 123(45):2138-46. PubMed ID: 8266034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of Lipoprotein(a) levels between elderly and middle-aged men with coronary artery disease.
    Cicek H; Bayil S; Zer Y; Celik A; Geyikli I
    Ann N Y Acad Sci; 2007 Apr; 1100():179-84. PubMed ID: 17460176
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Detection of serum Lp(a) level of coronary heart disease and its clinical significance].
    Liang XH; Huang CZ
    Hunan Yi Ke Da Xue Xue Bao; 2001 Jun; 26(3):227-8. PubMed ID: 12536688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Plasma lipid peroxides in coronary heart disease.
    Oen LH; Utomo H; Suyatna F; Hanafiah A; Asikin N
    Int J Clin Pharmacol Ther Toxicol; 1992 Mar; 30(3):77-80. PubMed ID: 1506121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.